Webinar about combination products: Bridging the gap between pharma and medical devices – Oct. 18

Wednesday, October 18, 2017 11:30am EDT / 8:30am PST   We will provide a new understanding of key topics that separate the regulatory and quality process for drugs and combination products/drug delivery devices.  We understand the process for drug development and certification varies greatly from the process for medical devices.  We will cover the intricacies

NIH awards $15M for 3D human tissue models

The National Institutes of Health has announced 13 two-year awards, totaling $15 million a year, for hospitals and universities to develop 3D human tissue models. The funding will go toward the first phase of a five-year program. Even though pre-clinical studies using cell and animal research models are promising, more than 60% of investigational drugs

Novartis CEO departs, leaving corner office to Harvard doc

Novartis‘ (NYSE:NVS) chief executive Joseph Jimenez is slated to leave his post next February, the drugmaker reported over the weekend. The CEO’s surprise departure leaves the corner office to Dr. Vasant Narasimhan, who currently serves as the company’s CMO and global head of drug development. The move comes just days after Novartis won FDA approval for […]

‘Body-on-a-chip’ device screens human heart cells for drug toxicity

Researchers at Kyoto University‘s Institute for Integrated Cell-Material Sciences have developed a ‘body-on-a-chip’ device that can evaluate the side-effects of drugs on human cells, according to a study published today in the Royal Society of Chemistry Advances. The device was used to test the toxicity of doxorubicin, a cancer-killing drug, on human heart cells. The researchers found

Sirtex swings to a loss after ‘challenging’ year

Shares in Australian cancer treatment developer Sirtex Medical (ASX:SRX) plunged more than 15% yesterday after the company posted a net loss of -A$26.9 million in 2016, compared to a profit of A$54 million the year before. Sirtex has faced a barrage of obstacles this year, including a number of clinical trials that failed to meet primary endpoints.

How a built-in refrigerator ice dispenser can dispense medication

An Arizona State University student recently designed an automatic medicine dispenser that could replace water and ice dispensers on refrigerators, according to a case study from Model Solution (Milpitas, Calif.). The device can dispense pills for two different users and gives audio and visual signals for the times that the users have to take their

Why Abbott’s CEO is excited about Bigfoot Biomedical and diabetes treatment

Just one week after Abbott (NYSE:ABT) said it inked a deal with Bigfoot Biomedical to develop an automated diabetes management system, CEO Miles White told analysts that he thinks Bigfoot is playing an important role in the strategic change taking place in the space. “It’s a fairly clever service and approach that I think will create, not just an

3 healthcare packaging trends you need to know

HealthPack 2017 earlier this year brought together a host of the country’s medical device packaging professionals, including directors and managers, packing engineers and research and development teams. Healthcare packaging is increasingly important in the medical device and pharmaceutical industry. Based on multiple panels and presentations, here are three important trends to look out for in

CMS spikes Medicare Advantage data release at the last minute

Medicare Advantage, privately run health plans paid for by Medicare, have covered an increasing number of seniors and disabled people in recent years. More than 1/3 of the 58 million Medicare beneficiaries opt for these non-traditional plans. The government has been collecting data about the care delivered to these enrollees since 2012. Last year, it

Drug delivery devices: Here is West’s plan for success

West Pharmaceutical Services is betting that an embrace of human factors engineering and experiential design will allow its drug delivery devices such as its SmartDose and SelfDose to stand apart from the crowd. People are more likely to take their medications properly if a device is easy to use, Eric Resnick, vice president and chief

Are nanoparticles overhyped?

Young startups backed by nanoparticle tech face a world hurdles before reaching the clinic. It’s been decades since the first innovations with nanotechnology – and experts are asking, “Where are all the drugs?” It’s been more than 20 years since the FDA approved the first nanoparticle drug, Doxil. At the time, nanoparticles were heralded as a

Vetter, Microdermics ink deal to develop novel microneedle drug delivery system

Prefilled drug delivery system developer Vetter and medical device maker Microdermics said yesterday that the companies are working to develop a novel microneedle drug delivery system. Microdermics has developed a low-cost, commercially scalable, customizable microneedle platform that delivers vaccines and biologics. The company said it expects its intradermal delivery system will enter Phase I clinical trials this

Trump proposes deep cuts to Medicaid, NIH funding

President Donald Trump’s proposed budget would slash Medicaid funding and cut support for major biomedical research programs at the National Institutes of Health and the Centers for Disease Control & Prevention. The budget blueprint drew condemnation from healthcare advocates and lawmakers from both sides of the aisle. Senate majority whip Sen. John Cornyn (R-Texas) reportedly said earlier

WSI Global offering Braille embossing capabilities

WSI Global – a manufacturer of finishing equipment for the carton converting, liquid packaging and corrugated industries – recently announced that it offers Braille capabilities, using either the TaskMaster infeed system or with a standalone unit that can be integrated into nearly any folder gluer. WSI’s Braille offerings are ideal for meeting European pharmaceutical industry

New medicines could eliminate uterine fibroid surgeries

Decision Resources Group, a healthcare research and data company, suggests that the launch of new medicines could provide a long-term management alternative to uterine fibroids surgeries over the next 10 years. Effective medical alternatives to surgical procedures will include novel selective progesterone receptor modulators (SPRMs) including Allergan and Gedeon Richter’s ulipristal, Bayer’s vilaprisan, and Repros’s